TheraSonic’s Post

The PSCC is proud to support Benoit Larrat, PhD, Anthony Novell and their spin-off TheraSonic from CEA. Click here to access the interview: https://lnkd.in/dM_Js7Cm and listen to Benoît as he presents his company, its challenges and his expectations from the PSCC. We are happy to offer them our full support, including premises to accommodate their first employees, training to secure non-dilutive financing and cybersecurity. We are also offering them access to our network of clinicians and pharmaceutical companies that will be their partners in developing their medical device. Their technology enables the crossing of the blood-brain barrier for drugs, particularly in oncology indications with high medical need, such as brain metastases, but potentially for all indications where this barrier is currently difficult to cross to deliver a treatment without compromising patient safety.   💡 #PSCCsupportedprojects make the news! #BBB #Innovation #Cancer